Dr. Forest Hand Sanitizer

Quercus Acutissima Whole, Chamaecyparis Obtusa Whole, Cryptomeria Japonica Bark


Forest On Co., Ltd
Human Otc Drug
NDC 81609-201
Dr. Forest Hand Sanitizer also known as Quercus Acutissima Whole, Chamaecyparis Obtusa Whole, Cryptomeria Japonica Bark is a human otc drug labeled by 'Forest On Co., Ltd'. National Drug Code (NDC) number for Dr. Forest Hand Sanitizer is 81609-201. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Dr. Forest Hand Sanitizer drug includes Chamaecyparis Obtusa Whole - 1 mg/100mL Cryptomeria Japonica Bark - 1 mg/100mL Quercus Acutissima Whole - 1 mg/100mL . The currest status of Dr. Forest Hand Sanitizer drug is Active.

Drug Information:

Drug NDC: 81609-201
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Dr. Forest Hand Sanitizer
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Quercus Acutissima Whole, Chamaecyparis Obtusa Whole, Cryptomeria Japonica Bark
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Forest On Co., Ltd
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:CHAMAECYPARIS OBTUSA WHOLE - 1 mg/100mL
CRYPTOMERIA JAPONICA BARK - 1 mg/100mL
QUERCUS ACUTISSIMA WHOLE - 1 mg/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 19 Feb, 2021
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 23 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Forest On Co., Ltd
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:80ZNL1G5XY
5VB6Q5926T
0TVP714IPW
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
81609-201-01300 mL in 1 BOTTLE, SPRAY (81609-201-01)19 Feb, 2021N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antiseptic

Product Elements:

Dr. forest hand sanitizer quercus acutissima whole, chamaecyparis obtusa whole, cryptomeria japonica bark artemisia princeps leaf houttuynia cordata flowering top citrus junos fruit rind .beta.-thujaplicin water green tea leaf pinus sylvestris cone quercus robur wood rosa rugosa flower bud orange oil rosemary oil lemon oil eriobotrya japonica leaf citrus maxima fruit rind oil apple wood rosewood oil cydonia oblonga leaf morus alba leaf paulownia tomentosa whole betula pubescens leaf prunus x yedoensis leaf quercus acutissima whole quercus acutissima whole cryptomeria japonica bark cryptomeria japonica bark diospyros kaki leaf lavender oil jasminum officinale flower chamaecyparis obtusa whole chamaecyparis obtusa whole juglans regia whole cupressus sempervirens bark

Indications and Usage:

Directions apply small amount to hands, rub hands together vigorously until dry. do not wash with water

Warnings:

Warnings for external use only avoid contact with eyes, in case of contact, rinse eyes thoroughly with water.

Dosage and Administration:

Use to help reduce bacteria on the skin

Stop Use:

Stop use and ask a doctor if irritation or redness develops.

Package Label Principal Display Panel:

Package label 81609-201-01


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.